Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 491 results for "glenmark pharmaceuticals"

Glenmark net profit increases 43.85% in Q1

Wipro Net Soars, LIC Housing Sales Advance

6:00 PM Mumbai Ambuja profit surged 26%. Bharti Infratel net jumped 29%. Colgate net jumped 4% on 13% sales increase. Glenmark net climbed 44%. HT Media net plunged 31%. Indian Bank profit tumbled 35%. MMFSL net declined 16%. PNB net climbed 10%. Ticker, 16 hours ago
Glenmark net soars 44% in April-June Times of India, 5 days ago
Glenmark net profit increases 43.85% in Q1, 5 days ago

28 images for glenmark pharmaceuticals

Pharma Letter, 4 days ago
European Pharmaceutical Manufacturer, 1 week ago
Sify, 4 days ago, 2 weeks ago
ABC News 4 Charleston, 1 week ago
I Stock Analyst, 1 week ago
KSWT13, 1 week ago
PR Newswire, 1 week ago
Pharma Letter, 1 month ago
Manufacturing Chemist, 1 month ago

Central Bank of India leads gainers in 'A' group

Hindustan Unilever, Reliance Power, Glenmark Pharmaceuticals and Jaiprakash Power Ventures are among the other gainers.
 Business Standard1 day ago

Glenmark Pharmaceuticals To Build its First Facility in the US

Mumbai India-based Glenmark Pharmaceuticals Ltd, a research-driven, global, integrated pharmaceutical company, plans to set up a new manufacturing facility in the U.S. The facility will be situated in Monroe, North Carolina, at the Monroe Corporate ...
 CoStar Group5 days ago Glenmark to set up new manufacturing facility in US  Individual.com1 week ago Glenmark Pharma to build new manufacturing plant in US  Pharmaceutical Business Review1 week ago Pharmaceuticals Newsletter – July 14 to 18, 2014  India Infoline1 week ago
Bio Spectrum Asia

Glenmark Generics receives ANDA approval

Telmisartan is Glenmark's generic version of Boehringer Ingelheim's Micardis Glenmark Generics has been granted final abbreviated new drug approval (ANDA) from the United States Food and Drug Administration (US FDA) for Telmisartan Tablets. ...
 Express Pharma1 week ago Glenmark receives ANDA nod for Telmisartan  Bio Spectrum Asia1 week ago Glenmark gets USFDA approval for skin infection cream  VC Circle2 weeks ago Glenmark Generics receives approval for Fluocinonide cream  Express Pharma2 weeks ago

Glenmark continues to struggle in US

Glenmark Pharmaceutical's 20 per cent sales growth in the June quarter suggests the company lacks any major growth trigger in FY15. Sales growth in the first quarter has been marred by anaemic growth in the US, as no new products have been launched. While ...
 Sify4 days ago Glenmark faces up to slower US growth  Livemint.com5 days ago

This is going to be challenging year in the US market: Glenn Saldanha

As the chairman and managing director of Glenmark Pharmaceuticals, Glenn Saldanha oversees a fast-growing organisation that spans from an India-focused branded generics business to a significant export market across major emerging and developed economies.
 DNA2 days ago Accord priority status to pharma and healthcare: Glenn Saldanha  DNA3 weeks ago

Pharma shares in demand; Healthcare index hits new high

Sun Pharma, Ranbaxy, Dr Reddy's Lab, Lupin, Glenmark, Wockhardt and Cadila Healtchare gained 1-8% on BSE.
 Business Standard4 days ago Healthcare and pharma: Fear of pricing action  Financial Express4 weeks ago Lupin, Dr Reddys Lab top picks in pharma space: ICICIdirect  Money Control3 weeks ago

Dr Reddy's, Glenmark, Ranbaxy to get astro support: Gupta

According to Satish Gupta of, pharma stocks like Dr Reddy's Laboratories, Glenmark Pharma, Shasun Pharmaceuticals and Ranbaxy Laboratories will be getting astrological support.
 Money Control4 days ago Lupin, Wockhardt, Glenmark to get astro support: Gupta  Money Control2 months ago

Glenmark surges 6%; Macquarie maintains outperform post Q1

Macquarie maintains outperform with a target of Rs 835 per share. The brokerage expects emerging markets strong growth momentum to continue and is hoping the US markets to pick up in second half, which was subdued due to lack of approvals in Q1FY15.
 Money Control4 days ago

Glenmark Q1 PAT may rise 26.3% at Rs 164.9 cr: P Lilladher

P Sales are expected to decrease by 0.8 percent quarter-on-quarter (growth of 34.8 percent Y-o-Y) to Rs 1668.6 crore, according to Prabhudas Lilladher. Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to fall by ...
 Moneycontrol.com5 days ago Glenmark may post Q1 bottomline growth at 29%: Poll  Money Control5 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less